Virtual Reality for ICU Delirium Prevention

ConditionICU Delirium
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCedars-Sinai Medical Center

About this trial

The purpose of this study is to evaluate whether daily exposure to immersive virtual reality (VR) can reduce the incidence of delirium in high-risk, non-intubated ICU patients. Participants will be randomized to either standard ICU care or standard care plus once-daily 15-minute VR sessions consisting of calming natural scenes, guided meditation, and music. The study population includes adult surgical ICU patients at Cedars-Sinai who are CAM-ICU negative at enrollment and possess at least one established risk factor for delirium. Outcomes will include the incidence and duration of delirium, ICU and hospital length of stay, feasibility of the VR intervention, and the frequency of adverse events. By targeting a high-risk population with an innovative non-pharmacologic therapy, this trial aims to generate data to support integration of VR into ICU delirium prevention protocols.

Eligibility criteria

Qualifiers

Individuals who are currently admitted to the SICU at Cedars-Sinai Medical Center

Expected ICU stay >48 hours

Richmond Agitation Sedation Scale (RASS) score between -1 to +2.

CAM-ICU negative

Disqualifiers

Unwilling and/or unable to participate

Intubation of tracheostomy

Self-reported history of severe motion sickness

Inability to follow commands (e.g. severe aphasia, deafness, GCS<13)

Trial design

Treatments tested in this trial

  • Virtual Reality therapeutics

Treatment groups

822 Participants
are divided into 2 treatment groups

Sponsors and collaborators